Twinbeech Capital LP Karyopharm Therapeutics Inc. Transaction History

Twinbeech Capital LP

  • $4.99 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$8.11 - $11.11 $129,662 - $177,626
-15,988 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$9.85 - $17.69 $157,481 - $282,827
15,988 New
15,988 $168,000
Q4 2020

Feb 16, 2021
SELL
$14.15 - $17.19 $412,161 - $500,710
-29,128 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$14.14 - $19.71 $411,869 - $574,112
29,128 New
29,128 $425,000

Others Institutions Holding KPTI

# of Institutions
95
Shares Held
56.5M
Call Options Held
258K
Put Options Held
81.2K
View Full List

About Karyopharm Therapeutics Inc.

KPTI Quotes by TradingView
  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $49.5M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track Twinbeech Capital LP Portfolio

Follow Twinbeech Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Twinbeech Capital LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email